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Abstract
The field of Global Health brings together a vastly 
diverse array of actors working to address pressing 
health issues worldwide with unprecedented finan-
cial and technological resources and informed by 
various agendas. While Global Health initiatives 
are booming and displacing earlier framings of the 
field (such as tropical medicine or international 
health), critical analyses of the social, political, and 
economic processes associated with this expanding 
field — an “open source anarchy” on the ground — are 
still few and far between. In this essay, we contend 
that, among the powerful players of Global Health, 
the supposed beneficiaries of interventions are ge-
nerally lost from view and appear as having little to 
say or nothing to contribute. We make the case for a 
more comprehensive and people-centered approach 
and demonstrate the crucial role of ethnography as 
an empirical lantern in Global Health. By shifting 
the emphasis from diseases to people and environ-
ments, and from trickle-down access to equality, we 
have the opportunity to set a humane agenda that 
both realistically confronts challenges and expands 
our vision of the future of global communities.
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Resumo
O campo da saúde global articula um diversificado 
leque de atores que trabalham para resolver pro-
blemas prementes de saúde em todo o mundo, com 
recursos financeiros e tecnológicos sem precedentes 
e munidos de agendas das mais variadas. Apesar 
das iniciativas em saúde global estarem crescendo 
de forma expressiva e deslocando enquadramentos 
anteriores do campo (como a medicina tropical ou 
saúde internacional), as análises críticas dos pro-
cessos sociais, políticos e econômicos associados a 
essa expansão ainda são escassas. Neste artigo sus-
tentamos, a partir de uma perspectiva que leva em 
conta os sujeitos, que o campo da saúde global é uma 
“anarquia de código aberto”. Em geral, perdem-se de 
vista os supostos beneficiários das intervenções, 
que aparecem como tendo pouco a dizer e nada a 
contribuir. Argumentamos por uma abordagem mais 
abrangente e centrada nas pessoas, demonstrando o 
papel crucial da etnografia como lanterna empírica 
na saúde global. Ao mudar a ênfase das doenças às 
pessoas e seus contextos e do acesso de cima para 
baixo para a equidade, temos a oportunidade de 
definir uma agenda humana que simultaneamente 
confronta realisticamente os desafios que enfren-
tamos e expande nossa visão sobre o futuro das 
comunidades globais.
Palavras-chave: Saúde Global; Economia Política; 
Produção de Evidências; Farmaceuticalização; Mu-
dança Social; Valores Humanos; Trabalho de Campo; 
Antropologia Médica.
Introduction
The field of “Global Health” brings together a vastly 
diverse array of actors and interests and it has 
become, in the words of economist Angus Deaton, 
“a big business” (Deaton, 2013; Brown, et al., 2006; 
Cohen, 2006; Fassin, 2012). The World Health 
Organization, the World Bank, the Gates Founda-
tion, pharmaceutical companies, governments, 
universities and innumerable nongovernmental 
organizations are all working to address pressing 
health issues worldwide with unprecedented finan-
cial and technological resources and informed by 
various agendas. While Global Health initiatives 
are booming and displacing earlier framings of the 
field (such as “tropical medicine” or “international 
health”), critical analyses of the social, political, and 
economic processes associated with this quickly 
evolving field — an “open source anarchy on the 
ground — are still few and far between. 
In this essay we contend that, among the power-
ful interests of Global Health, the supposed ben-
eficiaries of interventions are generally lost from 
view and appear as having little to say or nothing 
to contribute. While there have been efforts to 
engage civil society and activists, especially in 
the response to HIV/AIDS, there continues to be 
a strong biomedical orientation which sees civil 
society engagement as politically necessary but 
“scientifically” irrelevant. In other words, with the 
hope of a biomedical magic bullet reigning, the 
power of “data” defined in biomedical terms, the vi-
sion of technocrats tends to outweigh other forms 
of data and evidence. We make the case for a more 
comprehensive and people-centered approach and 
demonstrate the crucial role of ethnography as an 
empirical lantern in Global Health.
The stories and ideas we present come from close 
readings of the Global Health literature and our 
teaching of Medical Anthropology and Global Health 
courses. We also learn a great deal from the archival 
work of medical historians and the field studies of 
anthropologists seeking to understand the impact of 
Global Health interventions on health systems, go-
ver nance, and citizenship. Our independent research 
projects with marginalized communities dealing 
with treatment access for HIV/AIDS and psychiatric 
care (Biehl, 2005, 2007) and on the globalization of 
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clinical trials (Petryna, 2009; Petryna et al., 2006) 
have been critical to our understanding of social 
and political determinants of disease and health. We 
draw lessons from our co-edited book, When People 
Come First: Critical Studies in Global Health, which 
gathers vivid case studies focusing on the themes 
of evidence, interventions and markets in Global 
Health (Biehl and Petryna 2013). 
When using the term “critical” we have in mind 
Michel Foucault’s essay “What Is Critique?” Critique, 
he wrote, is a certain way of thinking, speaking and 
acting: “a certain relationship to what exists, to what 
one knows, a relationship to society, to culture, and 
also a relationship to others” (Foucault, 1997, p. 42). 
As such critique is “the art of not being governed 
quite so much” (p. 45). But critical thinking also 
entails imagining and desiring that things might 
be otherwise: “Critique only exists in relation to 
something other than itself [...] it is an instrument, 
a means for a future or a truth that it will not know 
nor happen to be” (p. 42). 
Critical thinking seeks epistemological break-
throughs. Such breakthroughs however do not 
belong to experts and analysts alone. The unpredict-
able and cumulative experiences of people navigat-
ing Global Health and humanitarian interventions 
and their aftermaths, we argue, can also produce 
breakthroughs that demand recognition. People’s 
practical knowledge compels us to leave comfort-
able disciplinary silos and to think of them not just 
as problems or victims, or patients or, worse, as 
vectors or disease carriers, but as complex agents 
with sometimes competing interests about the 
value of health and the meaning of wellbeing. That 
knowledge can also help us to better understand 
how larger systems and policies shape life chances 
locally, while at the same time keeping our attention 
to panoramas in flux. People on the ground recog-
nize what is troubling them and it is somewhere in 
the middle of social lives that the work of critique 
always begins. As ethnographers, we are uniquely 
positioned to see what more categorically minded 
experts may overlook: namely, the empirical evi-
dence that emerges when people express their most 
pressing and ordinary concerns, which then open 
up to complex human stories in time and space and 
that must become the center of public reflection 
and action.
Changing public health contexts
In the course of the twentieth century, innovations 
in public health and medicine helped to increase 
life expectancy at birth by almost thirty years in 
the United States and in other developed countries. 
Meanwhile, mortality rates remained high and life 
expectancies short in poor countries (Cutler et al., 
2006). Advances in medical technology continue to 
give cause for hope, as does the substantial increase 
in financial resources now available to address some 
of the world’s most pressing health challenges. New 
state policies, public-private partnerships, and mul-
tidisciplinary research collaborations are reshaping 
the field of Global Health and, in the process, putting 
older paradigms into question and transforming re-
alities on the ground. In key developing democracies 
— such as Brazil, India, and South Africa — we see 
activists and patients engaged in struggles over ac-
cess to high-quality care and, at a more fundamental 
level, debating the meaning, object and implications 
of health conceived as a right rather than a privilege 
or commodity (Biehl et al., 2012; Fassin, 2007).
Consider the story of Janira who lies in bed at 
home while her mother, Carmen, visits the public 
defender’s office in Porto Alegre, Brazil. Carmen 
is filing a lawsuit to obtain the medicine that her 
daughter urgently needs to treat severe pulmonary 
hypertension. A heart attack the year before led to 
a loss of mobility, and Janira has not been able to 
resume work. Her doctor has prescribed six medi-
cines; five are provided through Brazilian Unified 
Health System (SUS), while the Brazilian sixth, a 
high-cost vasodilator, is not. The doctor advised the 
low income family to seek free legal assistance at 
the public defender’s office.
Carmen hands the doctor’s prescription to the 
attorney Paula Pinto de Souza responsible for her 
case. Is it here that I get the medicine? she asks.
Souza welcomes Carmen to the juridical hospital, 
but she explains that getting the medicine will not 
be so simple. As a legal advocate for the poor and 
chronically ill, Souza’s job is to ameliorate suffering 
and to restore the rights of her clients. The person, 
she explains, comes here sick and wronged by the 
failure of public policies. We are beyond preventive 
medicine here and the concept of health as physi-
cal, mental and social wellbeing is no more. When 
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this infirmed person comes to me, the cure is most 
likely no longer possible. Her right to health has 
been profoundly injured by public power. Given the 
severity of Janira’s condition, Souza will ask the 
district judge to issue a court injunction compelling 
the state to provide Janira’s treatment right away. 
Carmen, whose husband died of cancer, is re-
tired and lives on a small pension. Her home is a 
one-room shack on the outskirts of the city, which 
she shares with her daughter and two granddaugh-
ters. A monthly course of the vasodilator Janira 
needs costs about US$1,000. Carmen has been 
purchasing the medicine in small amounts with 
borrowed cash, indebting herself to members of 
her extended family. At the same time, Carmen 
complains that she has already gone to the state 
pharmacy several times to obtain the five other 
medicines that Janira needs, and that should be 
publicly available, but they are always out of stock. 
She makes a little extra money performing Afro-
Brazilian rituals in her home and occasionally 
receives a food basket from her religious organi-
zation. When we visited the family, we noticed an 
offering to the orixás filled with packaged sweets. 
I do this so that all patients who need medicines 
win their lawsuits, Carmen explains.
What Janira really needs is a heart transplant, 
and all the medicines she takes are meant to keep 
her healthy enough to undergo the surgery. Janira’s 
brother, who lives in another shack on the same lot 
with his own family, routinely checks the status of 
her case at a nearby Internet cafe. Within days of the 
public defender’s filing, the district judge issued an 
injunction for the medicine to be delivered to Janira. 
Two months later it still had not arrived. 
When we returned a year later, Janira said that 
she was receiving the medication as a result of the 
injunction. The year before she could hardly get up 
by herself to go to the bathroom, and now she could 
help with house chores. She began to cry when she 
said that she could now take her daughters to school, 
which gave her immense pleasure.
At a time of great medical progress and amid 
Brazil’s economic boom, Janira is barely clinging to 
life. As she waited for her condition to improve to be 
able to qualify for a possible heart transplant, the 
family went into debt and judicialization became a 
last resort. The public health system was now finally 
working for Janira, but could it work fast enough 
to save her?
Attorney Paula Pinto de Souza considers the 
costs of lawsuits for treatment to the state to be 
negligible when compared to the scope of unrec-
ognized patients’ needs, but critics allege the judi-
cialization of health makes the health system less 
efficient and more unequal overall (Ferraz, 2009; 
Yamin and Gloppen, 2011). Janira and Carmen do not 
invoke rights and for them it does not matter if the 
life-extending medicine comes from the medical or 
the juridical hospital, as long as it comes. They are 
desperate but also resourceful and determined in 
their efforts. In their fight for life, they attempt to 
maintain healthy bodies but also healthy relation-
ships and households.
Indeed, the story of Janira and her family efforts 
is not unique. It reflects how broader questions of 
access to technology and social justice are playing 
out in today’s rapidly changing public health con-
texts. Fieldwork or home visits such as the one we 
have described can vividly capture these realities 
in flux. Accounts based on the experiences of real 
people — stories that are often obscured by abstract 
and bureaucratic considerations of public policy 
— are essential to comprehending the collision of 
a crushing burden of disease with emerging audit 
cultures and the new therapeutic regimes in which 
life chances unfold. Such accounts also point to the 
need for comprehensive care in Global Health and 
how it can be crafted. 
In what follows, we explore the concrete and 
unexpected effects of Global Health interventions, 
taking as case studies the magic bullet attempt 
to eradicate malaria in Mexico, the public-private 
treatment rollouts in Uganda and Mozambique, 
and the impact of evidence-based medicine in the 
design and implementation of public health inter-
ventions in Nepal and post-Katrina New Orleans. 
We argue that ethnographic evidence is essential 
for re-envisioning care and implementing different 
plans of action. The very concept of failure and of 
what counts as meaningful evidence of a successful 
intervention must also be scrutinized. 
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Through and beyond the magic 
bullet approach
When we look at international health interven-
tions historically, it becomes clear that the politi-
cal and economic requirements of the day and the 
ideological whims of the elites in charge determine 
how priorities are set and why they are abandoned. 
As social scientists unearth the recent history that 
explains how people become target populations in 
Global Health, unanticipated anthropological ter-
rains come into view: we find ourselves face-to-face 
with profound disconnections between campaign 
designs and intentions and the complex ways in 
which those campaigns are actually received and 
critiqued. The counter-knowledge of the people who 
are at the center of interventions is thus integral to 
assessing their actual impacts and to mitigating 
against blind spots and repetitions of history. 
In his book Cold War, Deadly Fevers, historian 
Marcos Cueto (Cueto, 2007) documents the story 
behind the Malaria Eradication Program that played 
a crucial role in Mexico’s public health policy during 
the politically charged years of the Cold War era. 
While constantly keeping in view the campaign’s 
international political implications, Cueto’s detailed 
account of the way the eradication campaign unfold-
ed in different locales leads him to document how 
the Rockefeller Foundation and elite national health 
experts campaign designs clashed with indigenous 
understandings. For example, many families living 
in rural Mexican communities simply refused to 
let the DDT sprayers into their homes. Cueto found 
cases of spontaneous protest escalating to armed 
conflict. After the first several years, even people 
who had complied with earlier rounds of DDT spray-
ing angrily noted that it worked less effectively every 
time, and that many insects seemed to be developing 
resistance and growing bigger instead of dying off.
In this charged historical moment, medical an-
thropology emerged as an applied social science. An-
thropologist Isabel Kelly, a former student of George 
Foster at Berkeley, began collaborating with Héctor 
García Manzanedo and the Mexican Health Secre-
tariat on rural projects in 1953. As the pair began 
researching how the malaria eradication program 
was being received by indigenous communities, 
they conceived their roles to be those of listeners 
and cultural brokers. Beyond the underestimated 
language barrier, their report noted many compli-
cations with respect to the program and why it was 
not achieving its anticipated success. For example, 
the medical anthropologists explored complex 
rotational housing patterns linked to seasonality, 
which meant families abandoned houses that had 
been sprayed or preferred to simply sleep outside 
in the heat of the summer. More fundamentally, 
indigenous communities often employed their own 
healing systems and understandings of fever that co-
existed uneasily with the public health information 
that government agents circulated about malaria. 
And, as the medical anthropologists would point 
out, underpinning this environment of suspicion 
were fundamental differences in health priorities. In 
many communities, malaria was not conceived of as 
a major health problem or even as a single disease, 
and many people in rural areas wondered why it was 
being singled out when other more pressing health 
concerns were being ignored.
This collision between local values and interna-
tional public health agendas was hardly just a fluke 
or footnote in the history of malaria eradication: 
Cueto’s complex portrait captures the fact that it 
was a key reason for the campaign’s ultimate failure. 
Without paying attention to how this intervention 
became embedded in local economies and politics, 
national health officials often treated social resis-
tance as a “communications problem” in a popula-
tion in need of education rather than as a problem 
of the design of the intervention itself. 
The implications of these realities run deep for 
our health policies today. In 2007, the Gates Founda-
tion revived the failed malaria campaign, pledging 
to eradicate the disease from the world (Cueto, 2013). 
A year earlier, the World Health Organization once 
again approved the spraying of houses as an appro-
priate part of malaria eradication. As Cueto notes, 
pyrethroid-soaked bednets and pharmaceuticals 
have become the technical fixes of a supposedly 
“new era” of magic-bullet approaches. Four decades 
after its original failure was declared in 1969, the 
goal of malaria eradication is now resurrected.
The fact is that the magic-bullet approach — the 
delivery of health technologies (usually new drugs 
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or devices) that target one specific disease without 
regard to the myriad societal, political, and eco-
nomic factors that influence outcomes — has been 
the norm in international health interventions for 
decades (Birn, 2005; Enserink, 2010; Stepan, 2011). 
There are, however, significant practical and episte-
mological downsides to this approach, which is now 
being challenged. Social scientists and health policy 
advocates caution that a narrow focus on the triad 
of technology delivery, patient compliance, and the 
basic science of disease, as important as these are, 
is insufficient. Also, unintended consequences may 
be unleashed by even the most carefully designed 
interventions (Larson, 2011).
The Global Health community has overempha-
sized individual risk factors that ignore how health 
risks are shaped by law, politics, and practices rang-
ing from industrial and agricultural policies to dis-
crimination, violence, and lack of access to justice. 
We need to better attend to breakdowns in public 
health systems and to the many political and social 
determinants of health (such as education, water, 
sanitation, vector control, air pollution, and accident 
prevention) that make people vulnerable to disease 
and injury in the first place (Amon and Kasambala, 
2009; Farmer, 2004; Freedman, 2005). Given the 
extreme inequalities that are so intricately woven 
into the current international order as well as into 
the social and political fabrics of countries and re-
gions (Deaton, 2013), we need integrated approaches 
that recognize the profound interdependence of 
health, economic development, good governance, 
and human rights. Any sustainable development has 
to reach and improve the conditions of the poorest 
and most vulnerable groups carrying the highest 
burdens of compromised health. Moreover, as is 
evident in Janira’s case, disease is never just one 
thing, technology delivery does not translate into 
patient care, and biology and technology interact 
in ways we cannot always predict. 
So, we must ask: What really happens when 
new treatments are introduced into epidemiologi-
cally diverse and variable social worlds? How is care 
organized by providers, and by state and nongov-
ernmental organizations? By what trajectories and 
means do the people who desperately need care ac-
cess it (or fail to access it)? And how can the stories 
of real people dealing with insecurities of all kinds 
find their way into and improve current practices 
in Global Health?
Projectified landscapes of care
In the twentieth century, international health ini-
tiatives were by and large implemented by states, 
subject to the coordination of specialized bodies 
such as the World Health Organization (WHO). In 
this paradigm, the main source of authority was the 
state, which took the lead in setting priorities and 
allocating resources. The politics of international 
health care were, as a result, subject to the usual 
constraints of diplomacy (Fidler, 2007), while the 
WHO and related bodies played a coordinating role, 
often using the discourse of human rights to ori-
ent and instigate efforts. These dynamics would be 
somewhat altered in the context of the United Na-
tions Millennium Development Goals (MDGs), which 
recognized health as an essential value and as a key 
pillar of development (United Nations, 2000). New 
forms of cooperation and intervention were estab-
lished to reach the targets of reducing maternal and 
child mortality and expanding access to treatment 
for infectious diseases, for example. In the process, 
the interests and practices of the private sector 
began to play a larger role in global public health. 
Humanitarian schemes and health system building 
have made common cause with the technical and 
financial know-how of the private sector.
We now see a multiplicity of actors, all vying 
for resources and influence in the political field of 
Global Health, each seeking to remain a relevant and 
powerful player. Ranging from the Gates Foundation 
to pharmaceutical company drug donation programs 
and PEPFAR (the [US] President’s Emergency Plan 
for AIDS Relief), to research initiatives, South-South 
cooperation and myriad rights-based pilot projects, 
these diverse interests are setting new norms for 
institutional response, sometimes providing the 
public health resources that states and markets can-
not or have failed to furnish. Locally, such multiple 
and fragmentary Global Health interventions con-
solidate what anthropologist Susan Reynolds Whyte 
and colleagues (Whyte et al., 2013) in Denmark and 
Uganda call “projectified” landscapes of care. 
Saúde Soc. São Paulo, v.23, n.2, p.376-389, 2014  381 
The Ugandan health system, at least as it re-
lates to HIV/AIDS, is almost exclusively dependent 
on international aid projects. After the civil war, 
Uganda’s government seized on health interventions 
to bolster its legitimacy abroad and at home. This 
welcoming attitude wins the Ugandan government 
a place in the world of international politics, as 
it demonstrates at once a willingness to lift itself 
from its ruinous recent history and, perhaps more 
importantly, to comply with neoliberal norms of 
state intervention. At home, the introduction of 
international actors provides much-needed relief 
to people living with HIV/AIDS and their families, 
and enables the government to present itself as at 
least partially providing health care to its populace.
In their longitudinal fieldwork with the first 
generation of AIDS patients who has had access to 
antiretroviral therapies and thus to a second chance 
at life, Reynolds Whyte and colleagues describe 
those who benefit from these health initiatives as 
“clients,” a felicitous term that can be understood 
in both contrasting and complementary senses. 
One, which harks back to Uganda’s political past, 
points to the ways in which these persons, who enjoy 
little power or resources other than those afforded 
through social networking, must seek out patrons 
better positioned within the world of health care 
in order to gain access for themselves. The other 
meaning of “client” echoes neoliberal trends which 
inform much of Global Health investment, and refers 
to persons as clients or consumers of a product (in 
this case heath care), thereby establishing a con-
tractual obligation between them and the providers 
of the product. 
Here health is not a “right” available to all 
citizens, but a service or thing available to those 
in the know and well-connected. “Good” clients are 
expected to be faithful to their programs and to help 
foster their growth. This “therapeutic clientship” 
becomes a support mechanism that extends well-
beyond the medical including possible employment, 
food access, and educational demands. An economy 
of loyalties and of financial, institutional, and medi-
cal sustenance is thus created. This “therapeutic 
clientship” stands in for citizenship and governance. 
The ethnographic analysis of Reynolds Whyte and 
colleagues offers a way to approach persons not 
exclusively as patients or as outcomes or failures 
of interventions, but rather as embedded actors 
moving within complicated social networks. This 
analysis provides a point of entry to assess the 
micropolitics in which health and health care are 
brokered, accessed, and transformed — and it gives 
us openings to think of ways to include those who 
have been left out. 
Global Health as open-source 
anarchy 
There is considerable confusion about how old and 
new players and initiatives fit together in a Global 
Health architecture, and how they inform the ongo-
ing debate about whether such architecture can and 
should be constructed and, if so, by whom and in 
whose interest (Cohen, 2006; Frenk, 2010; Keusch 
et al., 2010). In practice the concerns of donors, not 
recipients, tend to predominate (Easterly, 2006; Ep-
stein, 2007; Ramiah and Reich, 2005; Farmer, 2011). 
Often, donors insist on funding disease-specific 
and technologically oriented vertical programs at 
the expense of the public sector. And, whatever 
differences in interest and ideology may divide 
corporate, activist, and state public health agendas, 
the imperatives of “saving lives” and “increasing 
access” seem to reconcile these differences and fold 
them into an ethos of collective responsibility in the 
face of “crisis.” Global Health players can become 
impervious to critique as they identify emergencies, 
cite dire statistics, and act on their essential duty 
of promoting health in the name of “humanitarian 
reason” or as an instrument of economic develop-
ment, diplomacy, or national security (Fassin, 2011; 
Adams et al., 2008; Buss and Ferreira, 2010; Lakoff 
and Collier, 2008; Ventura, 2013). 
Despite the deluge of monies and organizations 
flowing into resource poor settings worldwide, local 
health systems continue to be woefully inadequate. 
We are also left with an “open-source anarchy” 
(Fidler, 2007) around Global Health problems — a 
policy space in which new strategies, rules, distribu-
tive schemes, and the practical ethics of health care 
are being assembled, experimented with, and impro-
vised by a wide array of deeply unequal stakeholders.
The anthropologist James Pfeiffer (Pfeiffer, 2013) 
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cuts an ethnographic path through the system of 
health care that has emerged in postsocialist, de-
mocratizing Mozambique and after the arrival of 
the US President’s Emergency Plan for AIDS Relief 
(PEPFAR) aid. The result of the divestment in the 
public sector is the creation of a fractured and 
uneven health system; state-of-the-art facilities for 
HIV/AIDS testing and treatment now coexist with 
all-but-dilapidated state hospitals where wealthy 
donors create showcase clinics in one region while 
the clinics in a neighboring region atrophy and their 
long-term sustainability is always in question. In 
this makeshift system, the Global Health focus is 
always at the level of the clinic, where interventions 
can be followed and their results measured. At-
tempts to make assessments at a national level are 
left by the wayside and the myriad social factors that 
can contribute to positive health outcomes are by 
and large ignored (or, if acknowledged, not acted on). 
Moreover, health workers are also in short supply 
outside spheres dominated by NGOs as limits are set 
on wages at public institutions and because NGOs 
can afford to pay more for specialized services.
Pfeiffer also shows how a poor national infra-
structure and terrible economic hardships intersect 
with everyday patterns of sociality to hinder HIV/
AIDS treatment adherence, especially among preg-
nant women. Pregnant women are at higher risk of 
being “lost to follow up” (LTFU) because they must 
confront a number of unique restrictions and risk-
laden choices that make treatment access perilous 
and adherence highly problematic. Faced with hun-
ger, difficulties in accessing treatment, the severe 
side effects of medication, and the stigma associated 
with AIDS, too many pregnant women drop out of 
programs.
Pfeiffer’s work draws attention to two important 
facets of a critical ethnography of Global Health. 
First, ethnographic accounts allow for a telling 
juxtaposition of scales (ranging spatially, from 
the pers pective of the patient and the community, 
to a much broader view that reveals the systemic 
flaws of the international financial impositions in 
Mozambique; and temporally, from the country’s 
socialist past to its market-fundamentalist present). 
Ethnography lays bare how interventions are woven 
into larger spheres of political economy and points 
to the impact of structural and economic factors on 
treatment and disease. Second, certain statistical 
and quantitative data can be productively reconciled 
with qualitative ethnographic approaches. “Lost to 
follow up,” for example, is not just a metric for judg-
ing the success or failure of a given intervention. 
Instead it is a starting point for looking beyond 
the limits such an evaluation imposes and into the 
reality of other factors (national economic systems 
and infrastructure, for instance) on the lives of the 
HIV-positive. Ethnographic evidence can provide 
new ways of looking at care and accountability; it 
can be put to use in developing different plans of 
action such as those carried out by Pfeiffer and 
Health Alliance International on the strengthening 
of primary care in Mozambique’s health care system.
Metrics and values 
Treatment access is one of the central tenets of Glob-
al Health activism and a professed goal of interven-
tions. Biological and medical sciences have greatly 
contributed to today’s therapeutic armamentarium, 
and the metrics of epidemiology and pharmacology 
have productively shaped the design and implemen-
tation of interventions. Amid fluctuations in fund-
ing, the field of Global Health has been consistently 
driven by scientifically based schemes of evaluation 
revolving around natural experiments, randomized 
controlled trials (RCTs), and statistical significance 
(Hammer and Berman, 1995; Anand and Hanson, 
1997; Duflo and Kremer, 2008). In this dominant 
regime of veridiction, evidence-based medicine has 
migrated to the realm of health interventions and 
has quickly positioned itself as the default language 
for both public and private-sector actors concerned 
with identifying problems and measuring outcomes 
(Deaton, 2010; Cartwright, 2011).
Anthropologist Vincanne Adams (Adams, 2013) 
studied a resiliency-training program for school-
age children in New Orleans and a safe-motherhood 
training program for Tibetan health workers. Both 
programs required health workers to participate in 
the new and unfamiliar economy of information on 
which the legitimacy of the programs rested. And, 
in both cases, the demands imposed by the now-pre-
dominant evidence-based medicine approach trans-
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formed not only the evaluation of the interventions, 
but also their methodologies, goals, and subjects. 
The New Orleans program could only be deemed 
reliable, credible and ultimately fundable through 
the acquisition of privately produced and interna-
tionally standardized assessment tools. In Tibet, 
the original project had to be radically altered on 
statistical grounds: it was not possible to determine 
whether the intervention was more effective than 
chance because “not enough women” died. Following 
the advice of a Maryland research consortium, the 
program — now upgraded to a “study” — was made 
“more scientific” and more globally comparable by 
abandoning training in safe motherhood and focus-
ing instead on infant mortality for which “better 
numbers” were available.
The advent of for-profit institutions as purveyors 
of services (be it the fulfillment of specialized func-
tions or an entire intervention) has demanded the 
incorporation of systematic economic assessment 
techniques, of which the cost-benefit analysis and 
the audit are the most salient. In this new landscape 
of Global Health saturated with NGOs and special-
interest groups, there is a movement toward mak-
ing interventions cost-effective and scalable. Thus, 
interventions themselves become producers and 
consumers of marketable and comparable informa-
tion. Entrepreneurship over capitalizable data has 
taken hold.
As Adams’s study shows, this new landscape of 
evaluation is displacing the previous goals of inter-
ventions, making the purveyance of actual health 
services secondary to the development of reliable 
methodologies, the generation of comparable data, 
and the training of a workforce capable of deploy-
ing interventions with similar results at a later 
date. Abandoned in this move are the experiences 
of the nominal targets of interventions. The focus 
is no longer on the sick and their caregivers, nor 
is much consideration given to the long-standing 
effects of programs on the lives of people and on 
public institutions.
RCTs have been given a free pass in the name of 
rigor, economist Angus Deaton argues. But there are 
no magic bullets and there are no gold standards 
(Deaton, 2012). With the hegemony of theoretical 
and technical fixes, the kinds of data we collect and 
our capacity to apprehend heterogeneity are compro-
mised. Moreover, biosocial approaches to disease 
and health that could help to specify dynamic causal 
connections and local politics are relegated to the 
low-authority category of “soft science” (Adams, 
2013; Krieger, 2011).
Consider the widely cited study by economists Kre-
mer and Miguel (2007) on curing worm infections in 
rural Kenya. Kremer and Miguel found that treating 
Kenyan schoolchildren with extremely cheap deworm-
ing medication increased their school attendance 
by roughly 10 percent. A New York Times op-ed piece 
heralded the study as “landmark” (Kristof, 2007): with 
just a bit of cheap medication, poor countries could 
increase school attendance by leaps and bounds. 
Given the affordability and stunning success of the 
treatment, many commentators suspected that fami-
lies who had not benefited from treatment during the 
study would very happily adopt this new technology.
But Kremer and Miguel (2007) observed a puz-
zling turn of events after the trial ended and when 
they followed a group of families outside the original 
cohort. Families who were friendly with families in 
the deworming treatment group were less likely to 
treat their children than those who were friendly 
with families in the control group. They were also 
less likely to deem the medication effective at im-
proving health. If deworming medicine is the pana-
cea for anemia and school truancy, then why were 
better informed families not treating their children?
Miguel and Kremer (2008) do not pinpoint the 
reason for the negative effect of this word-of-mouth. 
But they conjecture that the power of communica-
tion networks and people’s own understanding 
of worms as a social disease (not predicted in the 
study design) might have been at play. We have once 
again a case in which interpersonal relations and 
the needs and concerns of people on the ground, 
as well as their own sense of the complex ecology 
of disease, health, and medical technology, elude 
controlled studies. With its strict methodological 
imperatives, Global Health expertise often sacrifices 
the ethnographic evidence or counter-knowledge 
that is available as experiments and interventions 
(ever more closely linked) unfold — at the expense 
of better understanding and, ultimately, more mean-
ingful and long-lasting outcomes.
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The unpredictable social is not just an obstacle 
to or a means for perfecting theoretical tools and ex-
perimental strategies. Questions of how to account 
for persons in the context of their homes and rela-
tionships, and of how to involve local communities 
in the very design and implementation of feasible 
(rather than technology-enamored) interventions, 
pose continuous political, medical, and ethical 
challenges. With international and national health 
policy’s success largely framed in terms of provid-
ing and tallying the best medicines and newest 
technology delivered, what space remains for the 
development of low-tech or non-tech solutions (such 
as the provision of clean water) and the strengthen-
ing of local health systems and prevention efforts 
that could prove more sustainable than high-tech 
solutions alone? How can we escape the dystopic 
futures that are inscribed in present pragmatics?
Care 
Technocratic approaches (many times beholden to 
evidence-based medicine) can perpetuate limited un-
derstandings of narrowly conceptualized problems 
and support a rhetoric that offers only temporary 
control over isolated aspects of a given disease — a 
rhetoric that is aligned with the demands of funding 
organizations for immediate technical solutions. 
The obsession with scientific and economic pragma-
tism results in less attention to the social dynamics 
of programs and can lead to erroneous assumptions 
about generalizabilty, ie. that particular interven-
tions will work across countries and situations 
despite the fact that each will have distinct institu-
tions, practices, and rationalities, stubborn deficits, 
and persistent inequalities that will undercut the 
powers of overvalued magic bullets.
Global Health, according to business scholar 
Michael E. Porter, mirrors the limitations of health 
care delivery in the United States and “is stuck in 
an access and volume mindset, rather than focusing 
on the value delivered to patients” (Porter, 2009, 
2010). That is, narrow measurements of efficacy 
concentrate exclusively on the vertical intervention 
level and can assess only discrete preventative steps, 
drugs, or services. Porter and his colleagues call for 
a shifting of the goal posts, away from increasing 
access to treatments and toward delivering value 
for patients (Kim et al., 2010). The former goal as-
sumes a consumer-patient capable of seeking out 
and paying for appropriate treatment as long as it 
is available; the latter puts greater responsibility on 
health systems and providers for actively reaching 
the patient in need and attending to the full cycle 
of care and health outcomes for his or her medical 
condition. The focus must be on the results obtained 
by the patients (measured in survival rates and in 
the degree and sustainability of recovery) and not on 
a program’s success (measured, for example, by its 
compliance with standardized guidelines or by the 
number of drugs distributed).
A more holistic understanding of health is indeed 
needed and diverse disciplines (including anthropol-
ogy) must be engaged as we seek to understand the 
complexities of the context and content of health 
interventions as well as the trials and errors of real 
people in specific circumstances trying to figure out 
what works for them. Multi-scale empirical knowl-
edge of their efforts is crucial to the development 
of a patient-centered care delivery framework. This 
alternative knowledge can and should challenge 
the reductionist epistemic frameworks that tend to 
inform donors’ priorities and funding decisions as 
well as Global Health evaluation schemes. Moreover, 
a people-centered science of care delivery cannot 
fully flourish without it being grounded in a respect 
for human rights and structures of accountability 
and government obligation.
Anthropologist-physician Paul Farmer (Farmer, 
2004, 2011) is one of the most prominent proponents 
of a community-based equity approach that blends 
technological intervention with a focus on making 
health systems work. Farmer and Partners In Health 
(PIH), the organization he cofounded, understand 
diseases as loci where biology, environment, and 
medicine have gone awry; their concept of account-
ability and intervention accordingly tackles the 
structural conditions that perpetuate disease at the 
local level. In the interest of making the best care 
available to the poorest, Farmer and his colleagues 
reject economic orthodoxies such as demands for 
structural adjustments to eliminate health and 
education expenditures in the name of development, 
cost-effective benchmarks that limit the provision of 
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wraparound services, and human rights discourses 
that privilege political over socioeconomic rights 
(Farmer, 2008; Pfeiffer and Chapman, 2010). 
In Partners In Health’s social justice approach, 
accounting for individual patient trajectories and 
staying with patients throughout the course of their 
disease and rehabilitation (through the work of lo-
cal accompagnateurs) is as important as tackling 
the economic and social factors that impact families 
and mitigating the decay of clinical infrastructures. 
In this vision, the health care system is seen no lon-
ger as a drain on the economy, but as an enabler of 
social and economic development. While Farmer’s 
project is by no means accepted as a gold standard 
it has, along with other initiatives of this kind, made 
significant cracks in the prevailing rationalities 
that guide Global Health interventions and, above 
all, it has redefined the perceived boundaries of 
feasibility.
Conclusion 
There are profound discrepancies between how 
Global Health policies and campaigns are envisaged 
to work and the concrete ways in which they are actu-
ally implemented or received by target populations 
routinely facing multiple morbidities and economic 
insecurity (Han, 2013). So, how are we to measure 
the value of interventions for people, their health, 
and their subjective wellbeing, and how do interven-
tions affect health systems over time? And how can 
people and their advocates resocialize ill health and 
mobilize for a comprehensive right to health?
This essay calls for new and collaborative ways 
to understand and act on the transnational and local 
realities that are emerging in the shadow of large-
scale health and development interventions and 
in an era of ever-expanding global medicine. Amid 
broken public institutions and deepening rifts, the 
targets of Global Health interventions often implode 
the units through which they are conceptualized. In 
the meantime, the externalities created by interven-
tions that come and go are real  — leaving multivalent 
impacts on institutions and social relations that 
have to be addressed on their own terms and that 
people escaping grim medical destinies are left to 
reckon with. 
As showed in the field examples from Brazil, 
Mexico, Uganda and Mozambique, disease is multi-
layered and multiply determined, people are plural 
beings and not reducible to populations, and local 
realities still very much frame, constrain, and orient 
interventions. The agency of local actors is not lim-
ited to their blind acceptance or refusal of whatever 
form of knowledge, technology, or care is provided 
extralocally. Rather, people’s agency is bound to 
preexisting forms of exchange, politics, and desires 
as they find expressions, both new and old, in the 
changing landscape created by Global Health initia-
tives. Their everyday struggles and interpersonal 
dynamics have a way of eluding expert behavioral 
modeling and short-lived experimental approaches. 
The task of the social sciences in the field of Global 
Health is to break through these models, experi-
ments, and projections and to produce different 
kinds of evidence as we reckon with historical health 
disparities and the “pharmaceuticalization” of 
health care. We must also engage crucial questions 
about the role of the state and the market in Global 
Health design and delivery and investigate what 
happens to citizenship when politics is reduced to 
survival — all while maintaining a deep and dynamic 
sense of people in local worlds.
Engaging with the intricacies of people’s lives —
their constraints, resources, subjectivities, projects 
in unfixed social worlds — requires us to constantly 
reset our conceptual compasses and standards 
of evidence-making. What would it mean for our 
research methodologies and ways of writing to em-
brace this unfinishedness, to seek ways to analyze 
the general, the structural, and the processual while 
maintaining an acute awareness of the inevitable 
incompleteness of our own accounts?
People know what is troubling them. And it is 
somewhere in the thickness of social life that criti-
cal work always begins. Fieldworkers are uniquely 
positioned to see what more categorically minded 
experts may overlook: namely, the empirical evi-
dence that emerges when people express their most 
pressing and ordinary concerns which can open up 
to complex human stories in time and space. The so-
cial realities of “target populations” and the midlevel 
actors on whom the burden of implementation lies 
beg for analytic frameworks that weave intentions 
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together and for innovative genres that will allow 
people-centered evidence to add up, travel, and 
matter publicly and comparatively. By shifting the 
emphasis from disease to people and environments 
and from trickle-down access to equality, we have the 
opportunity to set a humane agenda that confronts 
the deep challenges the world faces and expands our 
vision of the future of global communities.
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